3-191329088-A-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_198152.5(UTS2B):c.-664-379T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0152 in 152,948 control chromosomes in the GnomAD database, including 67 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.015 ( 67 hom., cov: 33)
Exomes 𝑓: 0.0016 ( 0 hom. )
Consequence
UTS2B
NM_198152.5 intron
NM_198152.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.111
Publications
1 publications found
Genes affected
CCDC50 (HGNC:18111): (coiled-coil domain containing 50) This gene encodes a soluble, cytoplasmic, tyrosine-phosphorylated protein with multiple ubiquitin-interacting domains. Mutations in this gene cause nonsyndromic, postlingual, progressive sensorineural DFNA44 hearing loss. In mouse, the protein is expressed in the inner ear during development and postnatal maturation and associates with microtubule-based structures. This protein may also function as a negative regulator of NF-kB signaling and as an effector of epidermal growth factor (EGF)-mediated cell signaling. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Oct 2008]
UTS2B (HGNC:30894): (urotensin 2B) Predicted to enable G protein-coupled receptor binding activity. Predicted to be involved in regulation of blood pressure. Predicted to be located in extracellular region. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 3-191329088-A-G is Benign according to our data. Variant chr3-191329088-A-G is described in ClinVar as [Benign]. Clinvar id is 1250130.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0516 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
UTS2B | NM_198152.5 | c.-664-379T>C | intron_variant | Intron 1 of 8 | ENST00000340524.10 | NP_937795.2 | ||
UTS2B | XM_017006091.2 | c.-545T>C | 5_prime_UTR_variant | Exon 1 of 8 | XP_016861580.1 | |||
UTS2B | XM_011512631.3 | c.-545T>C | 5_prime_UTR_variant | Exon 1 of 8 | XP_011510933.1 | |||
UTS2B | XM_047447899.1 | c.-260-379T>C | intron_variant | Intron 1 of 7 | XP_047303855.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0152 AC: 2320AN: 152194Hom.: 66 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
2320
AN:
152194
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00157 AC: 1AN: 636Hom.: 0 Cov.: 0 AF XY: 0.00 AC XY: 0AN XY: 322 show subpopulations
GnomAD4 exome
AF:
AC:
1
AN:
636
Hom.:
Cov.:
0
AF XY:
AC XY:
0
AN XY:
322
show subpopulations
African (AFR)
AF:
AC:
0
AN:
8
American (AMR)
AF:
AC:
0
AN:
4
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
12
East Asian (EAS)
AF:
AC:
0
AN:
10
South Asian (SAS)
AF:
AC:
0
AN:
20
European-Finnish (FIN)
AF:
AC:
0
AN:
20
Middle Eastern (MID)
AF:
AC:
0
AN:
2
European-Non Finnish (NFE)
AF:
AC:
1
AN:
528
Other (OTH)
AF:
AC:
0
AN:
32
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.575
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.0153 AC: 2328AN: 152312Hom.: 67 Cov.: 33 AF XY: 0.0146 AC XY: 1085AN XY: 74482 show subpopulations
GnomAD4 genome
AF:
AC:
2328
AN:
152312
Hom.:
Cov.:
33
AF XY:
AC XY:
1085
AN XY:
74482
show subpopulations
African (AFR)
AF:
AC:
2223
AN:
41556
American (AMR)
AF:
AC:
74
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5170
South Asian (SAS)
AF:
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
11
AN:
68032
Other (OTH)
AF:
AC:
20
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
109
218
327
436
545
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
10
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Jan 13, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.